Sarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle–Brain Axis
Open accessThe DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Abstract
Declines in physical performance and cognition are commonly observed in older adults. The geroscience paradigm posits that a set of processes and pathways shared among age-associated conditions may also serve as a molecular explanation for the complex pathophysiology of physical frailty, sarcopenia, and cognitive decline. Mitochondrial dysfunction, inflammation, metabolic alterations, declines in cellular stemness, and altered intracellular signaling have been observed in muscle aging. Neurological factors have also been included among the determinants of sarcopenia. Neuromuscular junctions (NMJs) are synapses bridging nervous and skeletal muscle systems with a relevant role in age-related musculoskeletal derangement. Patterns of circulating metabolic and neurotrophic factors have been associated with physical frailty and sarcopenia. These factors are mostly related to disarrangements in protein-to-energy conversion as well as reduced calorie and protein intake to sustain muscle mass. A link between sarcopenia and cognitive decline in older adults has also been described with a possible role for muscle-derived mediators (i.e., myokines) in mediating muscle–brain crosstalk. Herein, we discuss the main molecular mechanisms and factors involved in the muscle–brain axis and their possible implication in cognitive decline in older adults. An overview of current behavioral strategies that allegedly act on the muscle–brain axis is also provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Second, decreased levels of myokines may account for the deterioration of cognitive function and neurodegeneration.289”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [289]
In the citing paper
“During ageing, the secretion of these myokines decreases.289”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [289]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907 · cited 1×
“Great attention has been paid to the age-associated declines in muscle mass and strength/function, given their close association with loss of mobility, disability, institutionalization, and mortality [1,3–7], besides being integral to the definition of frailty and sarcopenia [8,9].”
BackgroundCalcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 1×
“Great attention has been paid to the age-associated declines in muscle mass and strength/function, given their close association with loss of mobility, disability, institutionalization, and mortality [1,3–7], besides being integral to the definition of frailty and sarcopenia [8,9].”
BackgroundSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability
Guralnik, J. M., Ferrucci, L., Simonsick, E. M., Salive, M. E., & Wallace, R. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503023320902 · Cited by 4,083
Cruz-Jentoft, A. J., & Sayer, A. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31138-9 · Cited by 3,905
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909
Sarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“289 Additionally, a 1-year increase in the muscle BA increases the brain BA by 13 days.”
Granic, A., Suetterlin, K., Shavlakadze, T., Grounds, M. D., & Sayer, A. A. (2023) · Clinical Science · doi:10.1042/cs20230319 · Cited by 135
“Also of increasing interest is wider inter-connectivity between skeletal muscles and the brain via circulating systemic factors produced by contracting muscles, with links between sarcopenia and many aspects of cognitive dysfunction [166,309,310].”
BackgroundVascular Impairment, Muscle Atrophy, and Cognitive Decline: Critical Age-Related Conditions
de Lima, E. P., Tanaka, M., Lamas, C. B., Quesada, K., Detregiachi, C. R. P., Araújo, A. C., Guiguer, E. L., Catharin, V. M. C. S., de Castro, M. V. M., Junior, E. B., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12092096 · Cited by 73
The brain–body energy conservation model of aging
Shaulson, E. D., Cohen, A. A., & Picard, M. A. (2024) · Nature Aging · doi:10.1038/s43587-024-00716-x · Cited by 85
Tanaka, M., Szabó, Á., & Vécsei, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312767 · Cited by 58
“The muscle–brain axis has emerged as a significant area of research, highlighting how skeletal muscles influence brain function, particularly through the modulation of the KYN pathway [336–338].”
Skeletal muscle reprogramming enhances reinnervation after peripheral nerve injury
Mehrotra, P., Jablonski, J., Toftegaard, J., Zhang, Y., Shahini, S., Wang, J., Hung, C. W., Ellis, R., Kayal, G., Rajabian, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53276-4 · Cited by 58
“BDNF issecretedbybothmotorneuronsandmyo fi bersattheNMJ,andplays a role in postsynaptic maintenance, acetylcholine release, and motor neuron viability 97 – 99 .”
The Complexity of Oxidative Stress in Human Age-Related Diseases—A Review
Płóciniczak, A., Bukowska‐Olech, E., & Wysocka, E. (2025) · Metabolites · doi:10.3390/metabo15070479 · Cited by 51
Linking sarcopenia, brain structure and cognitive performance: a large-scale UK Biobank study
Gurholt, T. P., Borda, M. G., Parker, N., Fominykh, V., Kjelkenes, R., Linge, J., van der Meer, D., Sønderby, I. E., Duque, G., Westlye, L. T., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae083 · Cited by 40
“5,12 While few prior studies exist, there are studies implicating parietal grey matter 13 and white matter microstructural 14 alterations amongst individuals with sarcopenia.”
BackgroundInfluentialAraújo, L. P., Godoy, A. C. F., Frota, F. F., Lamas, C. B., Quesada, K. R., Detregiachi, C. R. P., Araújo, A. C., Miglino, M. A., Guiguer, É. L., Haber, R. S. D. A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412147 · Cited by 40
“…for the study of biological aging and the phenomena it triggers, has supported the association regarding the pathophysiology behind physical functional decline, cognitive decline, and sarcopenia, which share physiological pathways and processes that culminate in these diseases [74,174–177].”
Holland, C., Dravecz, N., Owens, L., Benedetto, A., Dias, I. H. K., Gow, A. J., & Broughton, S. J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102461 · Cited by 34
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders
Duranti, E., & Villa, C. (2024) · Biology · doi:10.3390/biology13090719 · Cited by 34
“Personalized medicine approaches that tailor interventions to individual patient profiles hold promise for improving outcomes.”
BackgroundBorda, M. G., Landi, F., Cederholm, T., Venegas‐Sanabria, L. C., Duque, G., Wakabayashi, H., Barreto, G. E., Rodríguez-Sánchez, I., Canevelli, M., Cano, C. A., et al. (2024) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2024.100666 · Cited by 33
“36,37 The individual ’ s dietary habits should be discussed and speci fi c supplements should be recommended to meet the protein and calorie requirements.”
Cognitive frailty: A comprehensive clinical paradigm beyond cognitive decline
Cozza, M., & Boccardi, V. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102738 · Cited by 34
Current Perspectives: Obesity and Neurodegeneration - Links and Risks
Kueck, P. J., Morris, J. K., & Stanford, J. A. (2024) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s388579 · Cited by 37
“63 Sarcopenia can begin as early as age twenty-five 64 and progresses thereafter.”
BackgroundDan, Y., Xiong, Y., Xu, D., Wang, Y., Yin, M., Sun, P., Ding, Y., Feng, Z., Sun, P., Xia, W., et al. (2025) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2025.1471433 · Cited by 29
“At the same time, mitochondria also play an important role in intracellular signaling in neural connections to skeletal muscle (Arosio et al., 2023).”
Zhao, Y., Jiang, Y., Guo, Y., Pan, W., Tian, W., Tang, L., & Feng, X. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1652386 · Cited by 30
Koçyiğit, S. E., Bulut, E. A., Aydın, A. E., Dost, F. S., Kaya, D., & Işık, A. T. (2024) · Nutrition · doi:10.1016/j.nut.2024.112504 · Cited by 28
Vitamin D and Sarcopenia: Implications for Muscle Health
Fuentes-Barría, H., Aguilera-Eguía, R. A., Angarita, L., Rojas-Gómez, D. M., Alarcón-Rivera, M., López-Soto, O., Maureira-Sánchez, J., Bermúdez, V., Rivera-Porras, D., & Contreras-Velásquez, J. (2025) · Biomedicines · doi:10.3390/biomedicines13081863 · Cited by 27
“Unlike mass and strength, performance integrates dynamic and complex aspects of motor control, including neuromuscular coordination, cardiovascular efficiency, joint function, and central nervous system responsiveness [53,54].”
Blood-derived factors to brain communication in brain diseases
He, J., Zhang, Y., Guo, Y., Guo, J., Chen, X., Xu, S., Xu, X., Wu, C., Liu, C., Chen, J., et al. (2024) · 中国科学通报:英文版 · doi:10.1016/j.scib.2024.09.022 · Cited by 27
Wang, Y., Mu, D., & Wang, Y. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05035-9 · Cited by 26
“Skeletal muscle secretes myokines and peptides that safeguard brain structure and function, including cognition, through mediating muscle-organ interaction [28, 30, 31].”
BackgroundInoue, D. S., & Gomes, M. J. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100838 · Cited by 27
Kim, S., Wang, S., Kang, D. W., Um, Y. H., Yoon, H. M., Lee, S., Choe, Y. S., Kim, R. E. Y., Kim, D., Lee, C. U., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14054 · Cited by 24
“6 9 However, these relationships between muscle and thebrainweredemonstratedonlyinhealthysubjects.”
BackgroundOrnago, A. M., Pinardi, E., Grande, G., Valletta, M., Calderón‐Larrañaga, A., Andersson, S., Calvani, R., Picca, A., Marzetti, E., Winblad, B. G., et al. (2025) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2025.100715 · Cited by 22
Self-citationFrom Chronodisruption to Sarcopenia: The Therapeutic Potential of Melatonin
Fernández‐Martínez, J., Ramírez‐Casas, Y., Yang, Y., Aranda‐Martínez, P., Martínez-Ruiz, L., Escames, G., & Acuña-Castroviejo, D. (2023) · Biomolecules · doi:10.3390/biom13121779 · Cited by 23
Samuelsson, J., Marseglia, A., Wallengren, O., Lindberg, O. E., Dartora, C. M., Cedrés, N., Shams, S., Kern, S., Zettergren, A., Westman, E., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2024.105555 · Cited by 21
SuperAgers and centenarians, dynamics of healthy ageing with cognitive resilience
Islam, M. A., Sehar, U., Sultana, O. F., Mukherjee, U., Brownell, M., Kshirsagar, S., & Reddy, P. H. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111936 · Cited by 23
Advancements in sarcopenia diagnosis: from imaging techniques to non-radiation assessments
Lavalle, S., Scapaticci, R., Masiello, E., Messina, C., Aliprandi, A., Salerno, V. M., Russo, A., & Pegreffi, F. (2024) · Frontiers in Medical Technology · doi:10.3389/fmedt.2024.1467155 · Cited by 21
“…of sarcopenia is multifactorial and involves alterations in muscle protein turnover, hormonal changes (such as reduced levels of testosterone, growth hormone, and insulin-like growth factor-1, chronic in fl ammation, oxidative stress, mitochondrial dysfunction, and neuronal de fi cits (8 – 10).”
BackgroundCandow, D. G., & Moriarty, T. (2025) · Current Osteoporosis Reports · doi:10.1007/s11914-024-00895-x · Cited by 14
Bonilla, D. A., Stout, J. R., Candow, D. G., Jiménez‐García, J. D., Gómez-Miranda, L. M., Ortiz-Ortiz, M., Forbes, S. C., Ostojić, S. M., Vargas-Molina, S., & Kreider, R. B. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1496544 · Cited by 20
Choi, J.-W., & Balakrishnan, R. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01034 · Cited by 21
“Research suggests that the release of myokines triggered by exercise facilitates communication between the brain and muscles (Arosio et al., 2023).”
Progress in precision drug delivery systems for neurodegenerative diseases with muscle atrophy
Zhang, G., Hu, F., Zhang, Y., Li, D., Deng, Y., Yang, M., Huang, T., Deng, X., Li, Y., Fu, C., et al. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111027 · Cited by 18
Rosas‐Carrasco, Ó., Manrique-Espinoza, B. S., López-Alvarenga, J. C., Mena‐Montes, B., & Omaña‐Guzmán, I. (2024) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2024.100368 · Cited by 18
“Recent research has explored the muscle-brain axis, where myokines play a crucial role in regulating and mediating cognitive functions and higher-orderprocesses,suchaslearning,memory,andcoordination[51].”
Creatine and Cognition in Aging: A Systematic Review of Evidence in Older Adults
Marshall, S. D., Kitzan, A., Wright, J., Bocicariu, L., & Nagamatsu, L. S. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf135 · Cited by 20
Wang, C., Jin, B., & Lu, A. (2024) · Healthcare · doi:10.3390/healthcare12121206 · Cited by 16
“However, current research on the relationship between sarcopenia and cognitive decline is limited and needs to be further explored [18].”
BackgroundPrevalence of sarcopenia in middle-aged and older adults with cognitive impairment: a meta-analysis
Ye, J., Chang, L., Chen, R., Arifin, H., Wang, C., Chiang, K., Banda, K. J., & Chou, K. (2025) · Age and Ageing · doi:10.1093/ageing/afaf114 · Cited by 15
Shi, H., Huang, L., Wang, Q., Zhang, N., Lv, C., Lin, C., Shao, L., Xia, D., Zhao, Z., Yang, G., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003030 · Cited by 15
“Patients undergoing orthopedic surgeries, such as hip and knee replacements or fracture repairs, often experience prolonged periods of immobi-lity, which can lead to both physical deconditioning and cognitive decline [358] .”
Bottaccioli, A. G., Bologna, M., & Bottaccioli, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062759 · Cited by 19
“The connection between muscle deficits (sarcopenia) and cognitive deficits in the elderly has been studied [148], influenced not only by myokines, but also by hormones released by the bone.”
Ferrer-Ramos, P., Garnacho‐Castaño, M. V., Farrés, M. G., Faúndez-Zanuy, M., & Serra‐Payá, N. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105722 · Cited by 14
Yu, C., Meng, Z., Wang, X., & Xiao, J. (2025) · BMC Public Health · doi:10.1186/s12889-025-24746-1 · Cited by 13
“The shared pathophysiological mechanisms between sarcopenia and fall risk, including muscle degradation and neuromuscular impairment [14], have prompted increased academic interest in their relationship [15]– [16, 17].”
Ragusa, F. S., Veronese, N., Vernuccio, L., Dominguez, L. J., Smith, L., Bolzetta, F., Koyanagi, A., Monastero, R., & Barbagallo, M. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-024-02781-z · Cited by 16
Popescu, C., Aurelian, S.-M., Mirea, A., Munteanu, C., Vlădulescu-Trandafir, A.-I., Anghelescu, A., Oancea, C., Andone, I., Spînu, A., Suciu, A., et al. (2026) · Life · doi:10.3390/life16010068 · Cited by 12
“These alterations are further aggravated by inadequate protein intake or protein–energy malnutrition, which blunt anabolic responses despite apparently normal calorie intake [8,12,27].”
InfluentialImahori, Y., Qin, C., Tang, B., & Hägg, S. (2024) · GeroScience · doi:10.1007/s11357-024-01334-6 · Cited by 12
“Recent evidence suggests myokines might play a vital role in the cross-talk between skeletal muscle and the brain, helping to maintain cognitive function [59].”
Gené‐Morales, J., Juesas, Á., Saez-Berlanga, Á., Martin, E. G., Garrigues-Pelufo, L., Sandoval-Camargo, B. S., Martin-Rivera, F., Chulvi‐Medrano, I., Jiménez‐Martínez, P., Alix‐Fages, C., et al. (2025) · Nutrients · doi:10.3390/nu17091431 · Cited by 13
“Accumulating oxidative damage can exacerbate fatigue, impair cellular function, and accelerate declines in both muscle performance and cognitive ability [11,12].”
Ikeue, K., Kato, H., Tanaka, M., Yamakage, H., Kato, S., Iwasa, M., Oishi, K., Yamamoto, Y., Kanasaki, M., Masuda, I., et al. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13820 · Cited by 11
Mei, C. T. Y., Ying, S. S. S., Yanshan, D. L., Koh, S. V., Karthikeyan, G., Xia, O. J., Low, X. L., Quek, H. Y., Shuyi, A. O., Low, L. L., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0291702 · Cited by 11
The mitochondrial function of peripheral blood cells in cognitive frailty patients
Li, Q., Huang, T., Zhang, D., Wei, L., Li, G., Zhu, Q., Tong, Q., Ding, G., & Liu, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1503246 · Cited by 10
Nazareth, C. C. G., Scalli, A. C. A. M., de Oliveira, M. P. B., Souza-Gomes, A. F., Brito‐Costa, S., Furtado, G. E., & Cezar, N. O. D. C. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241299051 · Cited by 11
“Preventing the loss of muscle mass is crucial for maintaining biological functions such as muscle strength, basal metabolism, glycemic homeostasis, injury resistance, and disease predisposition in the body, 14 resulting in improved functional capacity, independence, and quality of life.”
Lin, C.-Y., Zhai, Y.-J., Wu, F., An, H.-H., Chen, T., Qiu, H.-N., Li, J.-B., & Lin, J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1498478 · Cited by 10
“Cognitive impairment, T2DM, and sarcopenic obesity share common pathophysiological mechanisms, including insulin resistance, mitochondrial dysfunction, oxidative stress, and systemic inflammation (Arosio et al., 2023; Xing et al., 2023; Booranasuksakul et al., 2024).”
Neural Cues and Genomic Clues: NGS Insights into Neurogenic Sarcopenia and Muscle Atrophy
Kupriyanova, D. S., Bilyalov, A. I., Filatov, N. S., Brovkin, S., Shestakov, D., Бодунова, Н. А., & Gusev, O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211185 · Cited by 9
“BDNF is also involved in maintaining NMJ integrity by regulating presynaptic acetylcholine release and postsynaptic structure, which is critical for preserving motor units with age [63].”
Li, J., Wang, Y., Zhai, M., Qin, M., Zhao, D., Xiang, Q., Shao, Z., Wang, P., Lin, Y., Dong, Y., et al. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15256 · Cited by 12
“63 Factors such as chronic inflammation, insulin resistance, oxidative stress, and hormonal fluctuations may contribute to this intricate relationship.”
Lee, J., Woo, H. D., Kim, J. H., Jung, E. J., & Lee, K. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-092448 · Cited by 9
“31 Additionally, sarcopenia often results in physical inactivity, which reduces blood flow to the brain and limits neurogenesis, both of which are vital for maintaining cognitive function.”
Chen, L., Li, D., Tang, K., Li, Z., & Huang, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33832 · Cited by 9
Li, X., Liu, B., Sekar, D., Sur, M., Reddy, J., Natarajan, S. K., Lund, P. J., & Yu, J. (2025) · Nutrients · doi:10.3390/nu17172902 · Cited by 8
Dong, X., Yu, Y., Li, J., Chai, X., Shan, W., Yan, H., & Lu, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1489185 · Cited by 8
Knapik, M., Kuna, J., Chmielewski, G., Jaśkiewicz, Ł., & Krajewska–Włodarczyk, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186527 · Cited by 9
“There is evidence that physical activity enhances secretion of myokines such as irisin, BDNF, FGF-21, meteorin and IL-6 [13,14,27,48,65,67].”
Risk of sarcopenia: A red flag for cognitive decline in postmenopause?
Vallejo, M. S., Blümel, J. E., Chedraui, P. A., Tserotas, K., Salinas, C., Rodrigues, M. A. H., Rodríguez-Vidal, D., Rey, C., Ojeda, E., Ñañez, M., et al. (2025) · Maturitas · doi:10.1016/j.maturitas.2025.108193 · Cited by 8
Farsi, D. N., McKay, G. J., Linden, G. J., McAlinden, M., Teeling, J. L., Passmore, P., Holmes, C., Patterson, C., McGuinness, B., & McEvoy, C. T. (2025) · Gerontology · doi:10.1159/000547314 · Cited by 6
Wu, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1709867 · Cited by 9
Muscular strength, endothelial function and cognitive disorders: state of the art
Sánchez-Martínez, Y., López-López, J., Gomez‐Montoya, I., Hernandez‐Quiñones, D., Ruiz‐Uribe, G., Rueda, Z. R. R., Garcia, R. G., & López-Jaramillo, P. A. (2024) · The Journal of Physiology · doi:10.1113/jp285939 · Cited by 7
“The term myokines include a wide range of molecules that include anti-inflammatory cytokines (IL-6, IL-7, IL-8, IL-15), brain-derived neurotrophic factor (BDNF), cathepsin B, irisin, myostatin and fibroblast growth factor 21 (FGF21) (Arosio et al., 2023).”
Iga, J., Yoshino, Y., Ozaki, T., Tachibana, A., Kumon, H., Funahashi, Y., Mori, H., Ueno, M., Ozaki, Y., Yamazaki, K., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241307878 · Cited by 6
“58 Mitophagy plays an important role in mitochondrial quality control, providing important insights into the mechanisms and potential treatments for neurodegenerative diseases.”
Thaliath, A. P., & Pillai, J. A. (2025) · Current Treatment Options in Neurology · doi:10.1007/s11940-025-00852-8 · Cited by 5
“Loss of muscle tissue has been implicated with cognitive decline related to cytokine release from skeletal muscle mediating the muscle-brain crosstalk [43].”
Su, S., Wang, R., Chen, Z., & Zhou, F. (2023) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2023.105302 · Cited by 5
Consumption of protein supplements/protein-fortified foods among young adults in Jeju
Lee, H. M., Jang, Y., Kim, S., & Ha, K. (2024) · Journal of Nutrition and Health · doi:10.4163/jnh.2024.57.2.261 · Cited by 5
Maimaitiyiming, M., Yang, Y., Jia, X., & Zhang, X. (2025) · Age and Ageing · doi:10.1093/ageing/afaf132 · Cited by 4
Hu, M., & Wang, X. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1574275 · Cited by 4
State-of-the-art insights into myokines as biomarkers of sarcopenia: a literature review
Moussaoui, O. R., Deligiannis, I., Petrov, P.-P. S., Velikova, T. V., & Assyov, Y. S. (2025) · International Journal of Physiology Pathophysiology and Pharmacology · doi:10.62347/rneq8696 · Cited by 4
Drew, K. L., Fedorov, V. B., Duddleston, K. N., & Tøien, Ø. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.70013 · Cited by 4
“28 Given the intricate connection between muscle and brain health in aging, the search for strategies to preserve cognitive function is increasingly important.”
Caña-Pino, A., & Marín-Rubio, A. (2025) · Healthcare · doi:10.3390/healthcare13182287 · Cited by 5
“These findings may reflect the natural progression of aging-related functional decline, particularly in the absence of specific neuromuscular stimuli [54,55].”
Dharmansyah, D., Rahayuwati, L., Defi, I. R., Pramukti, I., & Mutyara, K. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113247 · Cited by 5
Cognitive impairment, dementia and sarcopenia in geriatric patients - is there a relationship?
Shirolapov, I. V., Kurmaev, D. P., Bulgakova, S. V., & Treneva, E. V. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-228-8-181-195 · Cited by 4
Determinants of dementia risk among older adults with probable sarcopenia and sarcopenia
Lipoeto, N. I., Vanoh, D., Desmawati, D., Ishak, W. R. W., & Mohamed, R. (2025) · BMC Public Health · doi:10.1186/s12889-025-22065-z · Cited by 4
“Skeletal muscle releases several components such as myokines, cytokines and chemokines which are able to mediate muscle-brain signaling for coordinating complex functions such as learning, memory, and motor coordination as well as strengthening global cognitive function [45].”
CD9, a novel potential biomarker of sarcopenia
Yin, L., Li, N., Bai, P., Wu, S., Wang, X., & Lü, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-04331-7 · Cited by 6
“However, the pathogenesis mechanism of sarcopenia remains unclear, and studies suggest that it is associated with ageing, lifestyle changes, physical activity, nutritional levels, and neurological factors 9–11 .”
Kang, Y., Tang, Y., Kong, W., Zhu, T., & Chen, G. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1404308 · Cited by 5
Salazar‐Londoño, S., Pérez-Foucrier, V., Baldera, J. P., Aarsland, M., Venegas‐Sanabria, L. C., & Borda, M. G. (2025) · Journal of Aging Research and Lifestyle · doi:10.1016/j.jarlif.2025.100023 · Cited by 3
“Moreover, the muscle – brain axis suggests that skeletal muscle secretes myokines such as irisin, which promote synaptic plasticity, neurogenesis, and cognitive function [28, 29].”
Eguchi, T., Kabetani, K., & Ito, N. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70055 · Cited by 4
“Notably, the decreased cognitive function, including dementia, is a risk factor for sarcopenia [33].”
Zhang, K., Huang, S., Liu, M., Zhang, Y., Li, W., Luo, B., & He, P. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1708170 · Cited by 4
Jiang, T., Wang, P., Wu, J., Liang, X., Wang, Y., & Hu, X. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06811-x · Cited by 4
“Sarco-penia facilitates brain inflammatory responses, influences the progression of cognitive decline via the muscle-brain axis and reduces mitochondrial function [13].”
Ren, Y., He, X., Zhang, Z., Zhuang, M., Yin, G., Huang, L., & Chen, N. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06876-8 · Cited by 3
“Sarcopenia accelerates cognitive decline through mechanisms such as chronic inflammation, mitochondrial dysfunction, and disruption of the muscle–brain axis [60, 61].”
Zhan, S., Wu, S., Ma, Q., Hu, C., Hu, H., & Wang, M. (2026) · Age and Ageing · doi:10.1093/ageing/afag095 · Cited by 3
Wu, S., Wang, F., Feng, X., Xin, S., Li, X. Z., Zhao, J., Li, S., Meng, Z., Chen, H., Yang, Y., et al. (2026) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70683 · Cited by 3
Educational attainment, brain cortical structure, and sarcopenia: a Mendelian randomization study
Zhang, Y., Wang, R., Chen, Z., Zhou, F., & Su, S. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1415343 · Cited by 4
“The mediating effect of the brain cortical structure on the prevention of sarcopenia by EA may be realized by the confirmed muscle-brain cross-talk (19).”
BackgroundThe Association Between Possible Sarcopenia and Delirium Onset in Older Patients With Acute Stroke
Shiozaki, K., Nagano, A., Hanaoka, M., Uchiyama, Y., Domen, K., & Koyama, T. (2025) · Cureus · doi:10.7759/cureus.86993 · Cited by 3
“Furthermore, recent studies have proposed the existence of a muscle-brain axis [22,23], wherein muscle degradation contributes to neuroinflammation and impaired cognitive function.”
Deng, S., Guo, Z., & Liu, M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333266 · Cited by 3
“…to restricted activity, which further exacerbates the decrease in social participation, whereas SI-related neuroinflammation inhibits the secretion of myogenic neurotrophic factors (such as brain-derived neurotrophic factor (BDNF)) through the “muscle–brain axis”, damaging synaptic plasticity [10].”
Cognition as mediator of pulmonary function and risk of sarcopenia among older adults
Hu, Z., Tang, L., & Zhan, Y. (2024) · BMC Public Health · doi:10.1186/s12889-024-18848-5 · Cited by 3
“…be linked to alterations in NMJ, such as changes in the structure and arrangement of pre-and postsynaptic membranes, a decrease in the quantity of synaptic vesicles containing neurotransmitters, and a deceleration in axonal transport, which may play a role in the development of sarcopenia [16, 17].”
BackgroundHe, F., Li, Y., Xu, X., Zhu, S., Chen, Y., Liu, H., Zou, X., Xie, X., & Chen, Y. Y. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.051 · Cited by 3
Li, M., Kang, S., Huang, K., & Tong, T. (2025) · Nutrients · doi:10.3390/nu17071141 · Cited by 2
“As the global population transitions into a super-aged society, increasing attention is being paid to geriatric conditions such as sarcopenia, hypertension, and neurodegenerative disorders [1].”
Julio, M. D. S., Cardim, A. B. F., Kogati, K. A., Favoretto, A. G., Santana, C. D. S., Paschoarelli, L. C., & Mêdola, F. O. (2024) · Estudos Interdisciplinares sobre o Envelhecimento · doi:10.22456/2316-2171.143063 · Cited by 2
Yang, Q., Qiao, Y., Shi, P., & Huang, Z. (2025) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2025.100744 · Cited by 2
“Sarcopenia, in particular, exacerbates these effects by impairing muscle strength and function, which are essential for maintaining physical and cognitive health [56,57], and by reducing neuro-protective myokines such as irisin, further contributing to cognitive impairment [58,59].”
Hashmi, M. A., Verma, S., Math, R. G. H., Muralidharan, S., Pranesh, G., Sahana, M. P., Hariharan, N., C, M., Kamath, V., Yaligod, V., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-35476-8 · Cited by 2
Hou, Y., Long, R., Sun, Q., Zhang, Y., & Wang, K. (2026) · BMC Public Health · doi:10.1186/s12889-026-26389-2 · Cited by 2
“The biological link between sarcopenia and cognitive decline likely reflects interconnected muscle–brain and systemic pathways [6].”
Duarte², M. P., Nóbrega, O. T., Grangeiro, A. C. M., Moreira, D. C., de Roure, J. G. R., Vieira, F. A., Silva, M. Z. C., Mondini, D. R., Disessa, H. S., Adamoli, A. N., et al. (2026) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2026.03.002 · Cited by 2
A systematic review of the association between phase angle and cognitive function among older adults
Wang, L., Ho, M., Minamizaki, M., Kanoya, Y., & Zeng, D. (2026) · GeroScience · doi:10.1007/s11357-026-02250-7 · Cited by 2
The crossroads between osteosarcopenia and intrinsic capacity—a narrative review
Neto, N. J., Hajj‐Boutros, G., Lok, W., Borda, M. G., Prokopidis, K., Rammal, H., Rivas, D., Samhat, H., Baltasar‐Fernandez, I., Imani, M., et al. (2026) · The Journals of Gerontology Series A · doi:10.1093/gerona/glag102 · Cited by 2
Xu, Z., Qiu, G., Peng, T., Liu, Q., Du, Q., Zhang, W., Xu, Y., Liu, X., & Fang, P. (2026) · European Geriatric Medicine · doi:10.1007/s41999-026-01499-7 · Cited by 2
“A key element in this process is the dysregulation of the brain–muscle axis [10].”
Zhang, C., Liu, Y., Shen, J., Zhang, Y., Liu, Y., Zhang, K., Fan, G., Liao, J., Dai, D., Zeng, P., et al. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70325 · Cited by 2
“Lower BDNF levels are closely associated with reduced protein synthesis as well as increased degradation [32].”
Yu, B., Zhou, Z., Chen, G., Zhou, C., Lv, P., Guo, J., He, F., Li, H., Chen, B., Ma, L., et al. (2026) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2026.100931 · Cited by 2
“…stages," high-lighting the sequential progression of IC decline and providing a clear framework for understanding the transition toward MCR [40]. health centers should implement cluster-based management, e.g., regular sensory screening/rehabilitation for the prevalent Cluster 2 to reduce…”
Hacking Neuroplasticity: How AI Can Help Your Healthy Aging Brain
Shaffer, J. (2024) · Productivity Press eBooks · doi:10.4324/9781003462354 · Cited by 3
Baumgartner, N. W., Geer, E. A., Noh, K., Khatri, R. A., Lattyak, M., Hirai, D. M., Amireault, S., & Kao, S. (2025) · Journal of Sport and Exercise Psychology · doi:10.1123/jsep.2024-0121 · Cited by 2
Mutoh, T., Kataoka, H., Tatewaki, Y., & Taki, Y. (2025) · Nutrients · doi:10.3390/nu17101707 · Cited by 2
“Sarcopenia and dementia are major disorders that shorten life expectancies and increase proportionally with aging [4].”
Cheng, E. S.-W., Cheung, D. S. K., Chiu, A. T. S., Cheung, J. C., & Wong, D. W. (2025) · International Journal of Human-Computer Interaction · doi:10.1080/10447318.2025.2558017 · Cited by 2
“Common age-related conditions include cardiovascular diseases, sarcopenia (Arosio et al., 2023), sensory impairments (e.g., hearing loss, sight problems), osteoarthritis, heart diseases, frailty, falls, mild cognitive impairment (MCI), depression, dementia, and delirium (World Health Organization,…”
Metadata
- Authors
- Arosio, B., Calvani, R., Ferri, E., Coelho-Junior, H. J., Carandina, A., Campanelli, F., Ghiglieri, V., Marzetti, E., & Picca, A.
- Affiliations
- University of Milan (IT)
- Università Cattolica del Sacro Cuore (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Department of Geriatrics and Orthopedics, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
- Agostino Gemelli University Polyclinic (IT)
- Corresponding author
- Marzetti, Emanuele
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-04-12
- Volume
- 15
- Issue
- 8
- Pages
- 1853
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10142447
- OpenAlex
- W4365454587
- Cited by
- 165
- References
- 173
- Citations by year
- 2026: 68 · 2025: 53 · 2024: 41 · 2023: 3
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, cc-by)
- Funders
- Università Cattolica del Sacro Cuore (D1.2020, D1.2022, R.C.R. 2022)
- Centro Studi Achille e Linda Lorenzon (D1.2020, D1.2022, R.C.R. 2022)
- Italian Ministry of Health (D1.2020, D1.2022, R.C.R. 2022)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Keywords
- sarcopenia, cognitive decline, older adults, muscle-brain axis, myokines, muscle aging, mitochondrial dysfunction, inflammation, neuromuscular junction, physical frailty, geroscience, protein intake, caloric restriction, neurotrophic factors
- MeSH terms
- Frailty, Aged, Aging, Brain, Humans, Muscle, Skeletal, Sarcopenia, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.